דקסטרוז % 5 ו % 0.45 סודיום כלוריד להזרקה usp
teva medical marketing ltd. - glucose hydrous 5 g / 100 ml; sodium chloride 450 mg / 100 ml - solution for infusion - sodium chloride - source of water electrolytes and calories.
תיאותרים 200
trima israel pharmaceutical products maabarot ltd - theophylline anhydrous - טבליות בשחרור איטי - theophylline anhydrous 200 mg - theophylline - theophylline - long acting bronchodilator in the symptomatic relief and/or prevention of asthma and reversible bronchospasm associated with chronic bronchitis and emphysema
תיאותרים 300
trima israel pharmaceutical products maabarot ltd - theophylline anhydrous - טבליות בשחרור איטי - theophylline anhydrous 300 mg - theophylline - theophylline - long acting bronchodilator in the symptomatic relief and/or prevention of asthma and reversible bronchospasm associated with chronic bronchitis and emphysema
קפרה 1000 מג
cts ltd - levetiracetam - טבליות מצופות פילם - levetiracetam 1000 mg - levetiracetam - levetiracetam - - keppra is indicated as adjunctive therapy in the treatment of partial onset seizures with or without secondary generalisation in adults and children from 4 years of age with epilepsy. - keppra is indicated as adjunctive therapy in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with juvenile myoclonic epilepsy. - keppra is indicated as monotherapy in the treatment of partial onset seizures with or without secondary generalization in patient from 16 years of age with newly diagnosed epilepsy. - keppra is indicated in the treatment of primary gneralized tonic-clonic seizures in adults and adolescents from 12 years of age with idiopathic generalised epilepsy.
רנוולה טבליות 800 מג
sanofi israel ltd - sevelamer carbonate anhydrous - טבליות מצופות פילם - sevelamer carbonate anhydrous 800 mg - sevelamer - sevelamer - for the control of hyperphosphataemia in adult patients receiving haemodialysis or peritoneal dialysis.also indicated for the control of hyperphosphataemia in adult patients with chronic kidney disease not on dialysis with serum phosphorus ? 1.78 mmol/l.should be used within the context of a multiple therapeutic approach, which could include calcium supplement, 1,25-dihydroxy vitamin d3 or one of its analogues to control the development of renal bone disease.
פוסטר 1006
kamada ltd, israel - beclometasone dipropionate anhydrous; formoterol fumarate dihydrate - תמיסה לשאיפה - formoterol fumarate dihydrate 6 mcg/dose; beclometasone dipropionate anhydrous 100 mcg/dose - formoterol and beclometasone - beclometasone - foster is indicated in the regular treatment of asthma where use of a combination product (inhaled corticosteroid and long-acting beta2-agonist) is appropriate:- patients not adequately controlled with inhaled corticosteroids and 'as needed' inhaled short-acting beta2-agonist or- patients already adequately controlled on both inhaled corticosteroids and long-acting beta2-agonists.
ג'ארדיאנס דואו 5 מג 1000 מג
boehringer ingelheim israel ltd. - empagliflozin; metformin hydrochloride - טבליות מצופות פילם - empagliflozin 5 mg; metformin hydrochloride 1000 mg - metformin and empagliflozin
ג'ארדיאנס דואו 5 מג 1000 מג
boehringer ingelheim israel ltd. - empagliflozin; metformin hydrochloride - טבליות מצופות פילם - empagliflozin 5 mg; metformin hydrochloride 1000 mg - metformin and empagliflozin
קינרט 100 מג תמיסה להזרקה
megapharm ltd - anakinra - תמיסה להזרקה - anakinra 150 mg/ml - anakinra - anakinra - kineret is indicated for the treatment of the signs and symptoms of rheumatoid arthritis in combination with methotrexate, in patients with an inadequate response to methotrexate alone.
רנוולה אבקה 2.4 גרם
sanofi israel ltd - sevelamer carbonate anhydrous - אבקה להכנת תרחיף - sevelamer carbonate anhydrous 2.4 g/sachet - sevelamer - sevelamer - for the control of hyperphosphataemia in adult patients receiving haemodialysis or peritoneal dialysis.also indicated for the control of hyperphosphataemia in adult patients with chronic kidney diseasenot on dialysis with serum phosphorus ? 1.78 mmol/l.should be used within the context of a multiple therapeutic approach, which could include calcium supplement, 1,25-dihydroxy vitamin d3 or one of its analogues to control the development of renal bone disease.